Detalhe da pesquisa
1.
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial.
Eur J Haematol
; 111(2): 300-310, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321625
2.
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria.
Blood
; 135(12): 912-920, 2020 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978221
3.
Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication.
Blood
; 124(15): 2459-62, 2014 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25185266
4.
Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.
Haematologica
; 105(3): e95-e97, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413086
5.
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial.
Lancet Haematol
; 8(5): e344-e354, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765419
6.
[Myeloproliferative syndromes]. / Syndromes myéloprolifératifs.
Rev Prat
; 71(2): e39-e49, 2021 02.
Artigo
em Francês
| MEDLINE | ID: mdl-34160990
7.
[Not Available]. / Place du ruxolitinib dans la stratégie thérapeutique des syndromes myéloprolifératifs.
Bull Cancer
; 103(6 Suppl 1): S29-38, 2016 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-27494970
8.
Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study.
Bone Marrow Transplant
; 56(10): 2600-2602, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226670
9.
Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital.
Blood Cancer J
; 11(7): 129, 2021 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34262018
10.
Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
Clin Res Hepatol Gastroenterol
; 44(4): 410-419, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651075